Pharmacokinetics, safety, and efficacy of GM1 ganglioside in healthy subjects and patients with multiple myeloma: Two dose-escalation studies.
Eur J Pharm Sci
; 190: 106565, 2023 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-37586437
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peripheral Nervous System Diseases
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Eur J Pharm Sci
Journal subject:
FARMACIA
/
FARMACOLOGIA
/
QUIMICA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Países Bajos